BlackRock Investment Management’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$683K Sell
146,838
-2,025
-1% -$9.42K ﹤0.01% 2896
2016
Q3
$1.15M Sell
148,863
-224
-0.2% -$1.73K ﹤0.01% 2556
2016
Q2
$903K Buy
149,087
+8,102
+6% +$49.1K ﹤0.01% 2695
2016
Q1
$1.2M Buy
140,985
+17,090
+14% +$146K ﹤0.01% 2363
2015
Q4
$1.48M Buy
123,895
+9
+0% +$107 ﹤0.01% 2295
2015
Q3
$1.25M Sell
123,886
-1,557
-1% -$15.7K ﹤0.01% 2430
2015
Q2
$2.08M Buy
125,443
+41,382
+49% +$686K ﹤0.01% 2196
2015
Q1
$1.3M Buy
84,061
+6,027
+8% +$93.3K ﹤0.01% 2348
2014
Q4
$1.24M Buy
78,034
+9,424
+14% +$149K ﹤0.01% 2393
2014
Q3
$732K Buy
68,610
+870
+1% +$9.28K ﹤0.01% 2720
2014
Q2
$636K Buy
67,740
+18,635
+38% +$175K ﹤0.01% 2893
2014
Q1
$339K Buy
49,105
+6,775
+16% +$46.8K ﹤0.01% 3097
2013
Q4
$165K Hold
42,330
﹤0.01% 3221
2013
Q3
$213K Buy
42,330
+12,182
+40% +$61.3K ﹤0.01% 3163
2013
Q2
$193K Buy
+30,148
New +$193K ﹤0.01% 3162